|
Onship has not been established. Gastrointestinal: Nausea and vomiting, about 5 in 100 patients; anorexia and malaise, each about 1 in 100; mild transient abnormalities in liver function tests, about 1 in 100; rare reports of hepatitis; parotitis, rarely. Metabolic: Weight gain, about 1 in 100 patients; gynecomastia, about 1 in 1000; transient elevation of blood glucose or serum creatine phosphokinase, rarely. Central Nervous System: Nervousness and agitation, about 3 in 100 patients; mental depression, about 1 in 100; headache, about 1 in 100; insomnia, about 5 in 1000. Vivid dreams or nightmares, other behavioral changes, restlessness, anxiety, visual and auditory hallucinations and delirium have been reported. Cardiovascular: Orthostatic symptoms, about 3 in 100 patients; palpitations and tachycardia, and bradycardia, each about 5 in 1000. Raynaud's phenomenon, congestive heart failure, and electrocardiographic abnormalities i.e., conduction disturbances and arrhythmias have been re
clonidine effects Koob3 1Lab de Neuropsychobiologie des Désadaptations clonidine effects, Université de Bordeaux II clonidine effects, Bordeaux clonidine effects, France 2Depto de Fisiologia Médica y Biofísica clonidine effects, Universidad de Sevilla clonidine effects, Sevilla clonidine effects, Spain 3Department of Neuropharmacology clonidine effects, The Scripps Research Institute clonidine effects, La Jolla clonidine effects, CA clonidine effects, USA Correspondence: Dr S Caillé clonidine effects, Department of Neuropharmacology clonidine effects, CVN-7 clonidine effects, The Scripps Research Institute clonidine effects, 10550 N Torrey Pines Road clonidine effects, La Jolla clonidine effects, CA 92037 clonidine effects, USA. Tel: 858-784-7305; Fax: 858-784-7405; E-mail: scaille@scripps.edu Received: 13 April 2002 Revised: 5 July 2002 Accepted: 10 July 2002 ABSTRACT Previous pharmacological studies have implicated serotonergic brain systems in opiate-withdrawal-precipitated conditioned place aversion. To assess this hypothesis clonidine effects, we tested the effects of either (i) a near-total 5 clonidine effects, 7-dihydroxytryptamine-induced lesion (90% depletion) or (ii) an acute serotonin (5-HT) inhibition induced by the specific stimulation of 5-HT1A autoreceptors (8-OHDPAT 5& 45;100 g& 47;kg) clonidine effects, o clonidine effects.
clonidine effects Cally given for opiate detoxification) were also tested after inhibition of 5-HT transmission. Serotonergic lesions in morphine-dependent rats failed to alter naloxone-induced conditioned place aversion but increased the sensitivity to the protective effects of clonidine Acute neuropharmacological blockade of serotonin transmission also potentiated the clonidine effects on naloxone-induced conditioned place aversion. When combined with the 5-HT1A agonist 8-OHDPAT clonidine effects, clonidine was also found to be more potent. Further understanding of this serotonin noradrenaline interaction might help devise new therapeutic treatments for the acute opiate withdrawal syndrome.Revue Journal TitleNeuropsychopharmacology (Neuropsychopharmacology)  ISSN 0893-133X  CODEN NEROEW Source Source2003 clonidine effects,  vol. 28 clonidine effects,  no2 clonidine effects,  pp. 276-283 8 page(s) (article)  (1 p.1 2)Langue LanguageAnglaisEditeur PublisherElsevier Science clonidine effects, New York clonidine effects, NY clonidine effects, ETATS-UNIS (1987) (Revue)Mots-clés anglais English KeywordsInstrumental.
clonidine effects Clonidine were tested: 0 clonidine effects, 25 clonidine effects, 50 clonidine effects, 100 clonidine effects, 200 clonidine effects, 400 g& 47;kg i.p. for sham rats and 6 clonidine effects, 12 clonidine effects, 25 clonidine effects, 50 clonidine effects, 100 g& 47;kg i.p. for 5 clonidine effects, 7-DHT-lesioned rats (Clo-0 clonidine effects, Clo-6 clonidine effects, Clo-12 clonidine effects, Clo-25 clonidine effects, Clo-50 clonidine effects, Clo-100 clonidine effects, Clo-200 and Clo-400). Experiment 3: 8-OHDPAT Effects on Clonidine Protection of Naloxone-induced Condition Place Aversion: A Dose-Response Study with 8-OHDPATA total of 101 rats were made dependent on morphine and were assessed for naloxone-induced place aversion. On the fourth day clonidine effects, the conditioning phase began with naloxone 15 g& 47;kg s.c. (Nal-15). At each naloxone-pairing day clonidine effects, clonidine 50 g& 47;kg i.p. (Clo-50) was injected 60 min before naloxone. To induce acute inhibition of 5-HT transmission clonidine effects, rats also received injections of 8-OH-DPAT 20 min before naloxone. Doses of 8-OH-DPAT tested were 0 clonidine effects, 5 clonidine effects, 10 clonidine effects, 25 clonidine effects, 50 clonidine effects, 100 g& 47;kg s.c. clonidine effects, chosen based on their autoreceptor selectivity (Goodwin et al clonidine effects, 1987) (DPAT-0 clonidine effects, DPAT-5 clonidine effects, DPAT-10 clonidine effects, DPAT-25 clonidine effects, DPAT-50 and DPAT-100). Different control groups were formed to verif.
clonidine effects 
clonidine effects | | | | | |
clonidine effects
Erious rapid increase in your blood pressure (rebound hypertension) may occur when this drug is suddenly stopped or if you miss 2 or more doses in a row, especially if you have been taking it for a long time, at higher doses, or with a beta-blocker medication. Therefore it is important that you do not run out of clonidine. There have been reports of rare, but severe (possibly fatal) results, including stroke, from stopping this drug too quickly. If you must stop taking this drug, your dose should be gradually decreased over several days as directed by your doctor. When used for an extended period, this medication may not work as well and may require different dosing. Talk with your doctor if this medication stops working well (e.g., your routine blood pressure readings increase). 1 2 3 4 Next Printer-Friendly Format Email to a Friend Back to Medications IndexLast Editorial Review: 3 2 2005 MedicineNet provides reliable doctor produced health and medical information. Browse Topics Aller
|
bravenet.com